Tetra Radar · FDA Approvals · Decision date

Libervant: FDA decision date

Aquestive Therapeutics Inc (AQST) · 16 March 2027

Anaphylm (dibutepinephrine) sublingual film (SEVERE ALLERGIES, ANAPHYLAXIS) PDUFA goal date of March 16, 2027 >$1B1 Annual US Revenue Libervant® (diazepam) buccal film (ACUTE REPETITIVE SEIZURES) >$100M1 Potential Annual Product Sales AQST-108 (epinephrine) topical gel >$500M1 Annual Revenue Proprietary Growth Drivers Preclinical Clinical Filed Marketed…

Source: 8-K of 16 November 2026

The decision is pending.

Aquestive Therapeutics Inc on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.